Chandra Bhagat Pharma Allots 50 Lakh Convertible Warrants to Promoter Group
Chandra Bhagat Pharma Ltd 路 Acquisition/ Disposal of Shares 路 26 Oct 2026, 6:58 pm
Chandra Bhagat Pharma Allots 50 Lakh Convertible Warrants to Promoter Group Chandra Bhagat Pharma Limited's promoter group was allotted 50,00,000 convertible warrants via a preferential issue on 22nd Oct'26. Prior to the allotment, the promoter and PAC group held 55,09,056 equity shares, representing 73.02% of voting capital and 38.95% on a diluted basis. Following the warrant allotment, their total holding stands at 1,05,09,056 shares/warrants, elevating their post-conversion diluted shareholding to 74.29% across a total diluted share capital of 1,41,45,056 equity shares of face value Rs. 10 each.
Original exchange filing (PDF)
More announcements from Chandra Bhagat Pharma Ltd
- Outcome of the Board Meeting held on 13th November, 2026. 路 13 Nov 2026
- Outcome of the Board Meeting held on 13th November, 2026 for approval of un-audited result as on 30th September, 2026. 路 13 Nov 2026
- Chandra Bhagat Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Un-audited Result for .... 路 13 Nov 2026
- The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Samir Ramkant Dave 路 27 Oct 2026
- The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Chintan Vijay Makhecha 路 27 Oct 2026
- Please find attached disclosure under Reg 30 of SEBI (LODR) Regulations, 2015 for your reference. 路 22 Oct 2026
- Certificate for Non_Applicability of Corporate Governance Certificate for the quarter ended 30th September, 2026. 路 21 Oct 2026
- The Company has informed the stock exchange regarding receipt of In-Principle approval for issue of shares on preferential basis. 路 13 Oct 2026
